RCaz/eu-funding-proposals-sft huggingface dataset:
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Draft an executive summary for the EU project 'GHz nanoscale electrical and dielectric measurements of the solid-electrolyte interface and applications in the battery manufacturing line' (NanoBat) targeting Horizon 2020.

assistant: **Abstract**

Sustainable storage of electrical energy is one of this century’s main challenges, and battery production is one of the future key industries with an estimated market potential of 250 Billion Euros by 2025 as stated by the European Commission. We contribute to this by establishing an RF-nanotechnology toolbox for Li-ion batteries and beyond Lithium batteries. The specific focus is on the nanoscale structure of the 10-50 nm thick SEI (solid electrolyte interphase) layer, which is of pivotal importance for battery performance and safety, but which is difficult to characterize and optimize with currently available techniques. The toolbox contains new nanoscale high-frequency GHz methods that are ultra-fast and capable of testing and quantifying the relevant electrical processes at the SEI, several orders of magnitude better than currently available techniques. Nanoscale imaging of the SEI electrical conductivity at high GHz frequencies will be done for the first time, and impedance changes are measured during electrochemical processes, supported by advanced modelling and simulation techniques. Several methods are tested in pilot-lines, including advanced electrochemical impedance spectroscopy and a newly developed self-discharge method that shortens the electrical formation process in battery production from 2 weeks to 10 min. Finally, the new methods will be used for high-throughput incoming quality control in the battery module production at our automotive end users, where 30.000 cells will be tested per day. In summary, we develop a solid basis of GHz-nanotech instrumentation to improve cell production and testing, resulting in major advantages for manufacturers and customers, for instance reduced waste and energy consumption, and longer lasting batteries that are safer
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Describe how 'Harnessing reversibility of peptide Self-Assembly processes to Synchronise Extracellular Matrix substitutes with cellular driven tissue reconstruction' will create measurable scientific, societal and economic impact aligned with Horizon 2020.

assistant: **Impact**

Irreversible tissue loss is a common feature in a large spectrum of health conditions (e.g. aging, trauma, cancer, degenerative diseases, ischemia, etc), placing huge burdens in patient relatives and health care systems. Therapies aiming to restore tissue function will have a great impact in the health and quality of life of millions of people worldwide. Regenerative medicine is an interdisciplinary endeavour to create functional tissues and organs, where cell biology, biochemistry, chemistry and material sciences are central components to address human tissues complexity. The approach comprises the use of biomaterials that temporarily substitute the extracellular matrix (ECM). However, current engineered biomaterials have not fully matched the diverse functionality of native tissues. Thus, fundamental research in biomaterials for regenerative medicine has great potential to provide smart solutions to current bottlenecks in this scientific area.  In this project, biomaterials based on peptide self-assembly will be designed to take advantage of reversible supramolecular interactions, in order to create self-healing ECM substitutes. The dynamic nature of these materials will be addressed systematically in an attempt to copycat ECM turnover. So far, efforts from the materials scientific community have been mainly focused on controlling spatial and geometrical features. Perhaps it is time to start addressing consistently time variable controls in biomaterials design, and to pave the way to fully synchronise the biology and man-made materials’ “watches”. We expect that SynchroSelf will generate a new class of dynamic biomaterials that will enable scientists to study wound healing processes in vitro with unprecedented level of complexity and experimental control.


**Keywords
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Write a project proposal abstract for 'GMP manufacturing & GLP diagnostic: Towards a personalised phage therapy against antimicrobial resistance' to be submitted under Horizon 2020.

assistant: **Abstract**

Phage therapy, that is the therapeutic use of bacteriophages for the treatment of pathogenic bacterial infections, is a highly promising answer to the antibiotic resistant plague (500 000 deaths a year attributable to multi-drug resistant bacteria today, 10 million forecast by 2050).  In this hopeful field, Pherecydes Pharma, a French SME created in 2006, is currently the world leader of phage therapy, with a a unique selling point and value proposal:  (1) Patented technology; (2)   Curent product portfolio covering over 50% of human infections and almost 90% of multi-drug resistant ones; (3) Ability to manufacture phages in GMP conditions; (4) 1st company to launch a transnational, well-designed, well-controlled, multicentric clinical study; (5) French authorisation (ANSM) in 2017 to administrate Pherecydes Pharma bacteriophages under a compassionate use status.  Building on these successes, the PhagoPROD project aims at setting-up, optimising and scaling-up the GMP manufacturing and GLP diagnostics processes currently validated and demonstrated at laboratory scale. In that so, the ultimate objective is to achieve large-scale commercial exploitation of Pherecydes Pharma products first at the EU then at the USA levels (world reaching is planned in the long term).  In the frame of this future commercial exploitation, targeted final users will be patients suffering from bacterial infections, notably antibiotic-resistant ones. Customers (i.e. buyers of Pherecydes Pharma products) will be clinical prescribers and hospital pharmacists. In this regard, Pherecydes already benefits from strong and long-lasting relationships with many hospitals and clinical centres in France and in Europe, as well as with several patients' associations (e.g. Le Lien or Phagespoirs).
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Explain how 'New Developments in Competition Policy' goes beyond current state-of-the-art under Seventh Framework.

assistant: **Innovation**

My goal is to shed light on the competition implications of two recent much-talked about developments in business, namely the surge of new financial derivatives and the high bonuses paid out to CEOs. First, there has been a rapid expansion of financial markets in the last decade and the therein used instruments, so-called financial derivatives. These products are generally not publicly exchanged on a market, which makes it hard to know how much they are used. But it is, for example, estimated that derivatives consist of between 20% and 40% of the total daily value traded on the London Stock Exchange. This same opaqueness of financial derivatives –apart from having likely been one of the causes of the current economic difficulties- has created a new array of tools for firms to change the rules of the game into anti-competitive, yet hard to detect ways. For example, a firm can buy a contract such that it benefits from a rival’s share price to decrease, which is a credible commitment to behave aggressively against that rival. Second, the use of large bonuses for managers has received a lot of criticisms in the press lately. But it has been largely neglected in economic research that these bonuses may also affect how managers, and the firms they lead, compete. It may occur, for example, that bonuses may motivate managers to collude with their competitors. It is perhaps time to more deeply explore how bonuses -and more in general the design of contracts in the firm- may affect managers’ decisions to infringe competition laws. In my project, I shall study the competitive effects of widely used financial derivatives and executive bonuses, and I will do this both from a theoretical and empirical perspective.""
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Explain the overall concept, methodology and approach for the project 'Complexity and dynamics in human health: the interaction of biological, mental, behavioural, and social processes as a challenge for interdisciplinary efforts in complexity research' (CDHH).

assistant: **Concept**

At the beginning of this new century, the topic of health can be seen as an outstanding challenge for international scientific, political, and economic efforts. The objective of this proposal is the organization of a European Conference on the application of complexity research and non-linear dynamics to some of the most important questions of human health and health producing systems.The topics of the conference are: - Health as a complex bio-psycho-social process; - The actual research on salutogenesis and health psychology;- The state of the art of the brain -consciousness-problem and the mind-body-interaction.
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Write a project proposal abstract for 'Medical sensing and nanodevices' to be submitted under Sixth Framework.

assistant: **Abstract**

This project is a merging of the original proposals 510103 (NANODEV) and 510107 (MOECAB). NANODEV deals with nanotechnology, while MOECAB deals with blood sensing, hereinafter referred to as subproject 'Nanotechnology' and subproject 'Blood Sensing'. Subp roject 'Nanotechnology'. At present nanoscience mainly deals with the building blocks, whereas the development of devices is in an embryonic stage. The subproject aims at the development of industrial implementation of nanotechnology and comprises the stud y of semiconducting nanowires and new nanoscale electronic devices, in particular sensors with single-molecule sensitivity and nanosized memory cells. To achieve these goals, ToK experts should strengthen the subproject's knowledge base regarding one-dimen sional materials and structures, sensors and memories. The combination of scientifically experienced fellows together with the application knowledge present in the host organisation can fulfil the goal to translate knowledge on nanoscience into new and gro undbreaking devices. Subproject 'Blood Sensing'. Blood testing is a major industry in health care and a standard procedure in hospitals. Also at home, blood testing is inevitable for diabetes patients who test their blood glucose levels various times ever y day. In the EU 3-4% and the USA 6-8% people are diagnosed with diabetes. Currently, blood testing is done using a needle. The need for non-invasive blood analysis is crucial for improving diabetes treatment. At Philips Research a new non-invasive method is being explored. The challenge is to strongly reduce the cost price of the system, to realize introduction on the health care market. The subproject proposes development of multivariate optical element (MOE) technology to implement spectral analysis in l ow c
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Describe how 'Evolutionary responses to a warming world: physiological genomics of seasonal timing' will create measurable scientific, societal and economic impact aligned with Seventh Framework.

assistant: **Impact**

The world is seasonal and organisms’ adjustment of their seasonal timing to this environmental variation is crucial for their fitness. Climate change is strongly impacting seasonal timing which makes a better understanding of the potential for micro-evolution of timing in natural populations essential. As any phenotypic change ultimately involves changes in the physiological mechanism underlying timing, we need to unravel the genetics of these mechanisms. I will carry out a highly integrated eco-evo-devo project on the causes and consequences of genetic variation in timing of reproduction in great tits (Parus major), an ecological model species for that we recently developed state-of-the-art genomic tools. I will develop a powerful instrument to study this timing mechanism by creating selection lines of early and late reproducing birds using genome-wide, rather than phenotypic, selection. The phenotypic response of selection lines birds will be assessed both in controlled environment aviaries and in birds introduced to the wild. To unravel how selection has altered the birds’ physiology I will measure key components of the physiological mechanism at the central, peripheral and egg production levels. As a unique next step I will then introduce selection line birds into a wild population to assess the fitness of these extreme phenotypes. This will enable me, for the first time, to estimate the selection on timing without confounds, which I will compare with traditional estimates using observational data. Finally, I will integrate genetics, physiology and ecology to hindcast the rate of genetic change in our wild population and validate this rate using DNA sampled over a 20-year period. This innovative project integrates state of the art developments in ecology, genetics a
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Describe the novelty, innovation potential and advance beyond the state of the art for 'New high performance electro Rheological Fluids based on multilayered particles' (RHEOFLUX).

assistant: **Innovation**

Objectives and content Electro Rheological Fluids (ERFs) are suspensions of nonconductive, polarisable particles in a liquid medium, which reversibly change their rheology under an energising electrical field. The objective of this project is to develop a new type of ERFs with response times < 1 ms for high frequency (110 kHz) underwater acoustics applications and ERFs with electrical losses < 200 W/l for white goods vibration dampers and vehicle shock absorbers, working with high shear rates and low energising voltage even at elevated temperatures. Existing ERFs do not fulfil the demands of these applications, since compromises have to be accepted from trying to incorporate almost all required properties into one and the same particle composition. The technical innovation claimed in this proposal is the development of spherical multi-layered dispersed particles having an insulating core of adapted density and size to control sedimentation, a metallic coating, providing a high polarisation at relatively low voltages for short response times and a top coating for electrical insulation, tailored interfacial properties to liquids, assuring the long-term dispersibility and stability. The general approach for the material and process development is the use of wet chemical routes for the synthesis and processing of fine particles and stabilised suspensions, based on the basic technologies for the preparation of fine particles and a variety of functional coatings, available at partner INM. INM has already made such particles from commercially available hollow glass spheres of 40 mm in diameter. A copper layer was deposited electrolesson these particles and finally the particles were coated with TiO2 or borosilicate glass layers by spray drying and thermal treatment. Subsequent
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Draft the 'Objectives and Scope' section of a Horizon Europe proposal for the project 'Revitalisation of European local communities with innovative business models and social innovation in the blue bio-based sector.'.

assistant: **Objectives**

BlueRev aims to select a range of systems in the blue bio-based sector in 3 different pilot regions throughout Europe, i.e. Denmark, Italy and Estonia (pilot regions), to tailor value chains, from valorisation of co-products as feedstock to processing/conversion to final products, in order to revitalise local communities, both in a territorial and social sense and contribute to positive environmental and social impacts. The proposal will analyse these value chains according to social, economic and environmental barriers and potentialities, business models, local capacities such as feedstocks, infrastructure, human skills, etc., innovation actors, including community knowledge and marginalised groups, by using existing or improved monitoring system and indicators to evaluate the effectiveness of the value chains. The proposal will also analyse the existing governance framework and how it can be improved.The analysis will serve BlueRev to develop or replicate new governance  and business models allowing the transition towards socially and environmentally responsible behaviour within all ranges (e.g. regulatory measures, corporate  responsibility initiatives, education), to enable sufficient impacts and performances of the specific value chains and to allow replication across Europe. In doing that BlueRev will ensure an efficient engagement of all actors, including local and regional authorities, primary biomass producers, SMEs, civil society organisations including NGOs, knowledge providers, community knowledge and marginalised groups via robust and transparent communication and awareness-raising campaigns.


**Keywords:** blue bio-based sector, business models, regional and local communities
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Write clear, measurable objectives and define the scope for the project 'Stimuli Responsive Polymer Nanotubes by Initiated Chemical Vapor Deposition' (SRPNiCVD) under Seventh Framework.

assistant: **Objectives**

One dimensional nanotubular structures have a wide range of applications due to their unique physical and chemical properties that are different from the bulk materials. Metal and semiconductor nanotubes are being used as sensors, optoelectronic devices or transistors. Furthermore, polymeric nanotubes have great potential as biomedical devices due to the biocompatible nature of the polymers used. However, they are not as widely studied due to the difficulty of fabricating the nanotubular structures using common thin film deposition techniques. In this research, we propose to use initiated Chemical Vapor Deposition (iCVD) to fabricate polymer nanotubes. iCVD technique has been shown to successfully deposit polymer thin films while keeping the chemical moieties of the monomers intact. Furthermore, the crosslinking density and the wall thickness of the nanotubes can easily be tuned using iCVD as opposed to other techniques, such as solution-based techniques where the polymer should be soluble.Our proposal aims to develop nanocarrier systems of polymer nanotubes for various potential applications. A wide range of stimuli responsive polymers (SRP) will be used to fabricate the nanotubes and the mechanical and response characteristics of these nanostructures as a function of crosslinking density will be explored. In the next stage, coaxial nanotubes with both layers made of SRPs will be fabricated and the effects of the interaction between the layers on the release mechanism will be studied.The results of these studies will help us better understand the dominant mechanisms during uptake and release and thus enable us to fabricate the nanocarriers according to the response desired. Furthermore, these nanotubes with improved performance will have significant impact as drug deli